As the pharmaceutical industry continues to push the boundaries of innovation, the role of digital solutions like eCOA platforms will only grow in significance. For rare disease trials, where patient ...

Although Paxlovid did not demonstrate widespread efficacy, a novel approach to long COVID research has emerged.

Encouraged by initial successes with ketamine, researchers including Peter Nagele, a professor of anesthesia and psychiatry ...

Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...

A study of 634 allergy patients in Tenerife found that 22% were sensitized to edible insects—often without ever consuming ...

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective.

Three Brown University undergraduates and two recent alumni were named among this year’s classes of Goldwater, Truman, Gates ...

Chico, Vice President and Global Head of Oncology Therapeutic Expertise at Fortrea, shares how scientific advances, AI tools ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 ...

A large quasi-experimental study in Australia found that adults eligible for free shingles vaccination based on their date of ...

Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 ...